Paulo Roberto Carvalho Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paulo Roberto Carvalho Almeida has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Roberto César Pereira Lima-Júnior
Drug Research and Development Center Department of Physiology and Pharmacology Faculty of Medicine Federal University of Ceará Fortaleza Brazil
4 shared publications Deysi Viviana Tenazoa Wong
Univ Fed Ceara, Fac Med, Dept Pathol & Forens Med, Grad Program Pathol, BR-60441750 Fortaleza, Ceara, Brazil
2 shared publicationsJoão Paulo Aguiar Sampaio
Federal University of Ceará
2 shared publicationsRenato Braga Vieira
Federal University of Ceará
2 shared publicationsRoberto César Pereira Lima-Júnior
Univ Fed Ceara, Fac Med, Drug Res & Dev Ctr, Grad Program Pharmacol,Dept Physiol & Pharmacol, BR-60430275 Fortaleza, Ceara, Brazil
2 shared publicationsRonaldo Albuquerque Ribeiro
Federal University of Ceará
2 shared publications
Latest Publications
- 1 October 2021
- Published by Elsevier in Acta Histochemica
- Vol. 123 (7) , 151787
Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133
- 1 October 2021
- Published by Elsevier in Acta Histochemica
- Vol. 123 (7) , 151787
Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133
- 1 December 2020
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (12) , 153265
Cytoplasmic CCR7 (CCR7c) immunoexpression is associated with local tumor recurrence in triple-negative breast cancer
- 1 December 2020
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (12) , 153265
Cytoplasmic CCR7 (CCR7c) immunoexpression is associated with local tumor recurrence in triple-negative breast cancer
- 13 March 2015
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 24 (6) , 1367-1376
Immunoexpression of metalloproteinase 14 and tissue inhibitor of metalloproteinase 2 in colorectal carcinomas and lymph node metastases
- 13 March 2015
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 24 (6) , 1367-1376
Immunoexpression of metalloproteinase 14 and tissue inhibitor of metalloproteinase 2 in colorectal carcinomas and lymph node metastases
- Open Access
- 1 October 2014
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 29 (10) , 667-674
Progressive loss of E-cadherin immunoexpression during cervical carcinogenesis
Key words: Cadherins; Immunohistochemistry; Cervical Intraepithelial Neoplasia; Neoplasms squamous cell; Uterine Cervical Neoplasms
- 1 October 2014
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 29 (10) , 667-674
Open AccessProgressive loss of E-cadherin immunoexpression during cervical carcinogenesis
Key words: Cadherins; Immunohistochemistry; Cervical Intraepithelial Neoplasia; Neoplasms squamous cell; Uterine Cervical Neoplasms
- 1 August 2014
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 74 (4) , 711-720
Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model
Nonalcoholic steatohepatitis (NASH) has been associated with irinotecan (IRI)-based cancer chemotherapy regimens. The purpose of this study was to propose and test a consistent model of IRI-induced NASH, filling a gap in the medical literature. Swiss male mice were distributed in groups (n = 8) and injected with saline (5 mL/kg, i.p.; control) or IRI (25, 50, 75 or 100 mg/kg, i.p.) thrice a week for 7 weeks. Blood samples were collected to measure the serum concentrations of proteins, alanine and aspartate aminotransferases (ALT and AST). Each week animals were euthanized, and the livers were submitted to myeloperoxidase (MPO) assay, lipid dosage, immunohistochemistry for inducible nitric oxide synthase (iNOS), TNF-α and interleukin-1β (IL-1β), and histopathological analysis. Survival rates were also determined. Mice treated with IRI had a significantly (p < 0.05) lower survival rate than controls and time- and dose-dependent body weight loss. ALT and AST plasma levels increased in relation to controls only in mice receiving IRI 50 mg/kg (p < 0.05). The histopathological features characteristic of NASH was observed, including steatosis, lobular neutrophil infiltration and ballooning hepatocytic degeneration. Additional findings included increased MPO, lipid accumulation, portal neutrophil infiltration, IL-1β and iNOS expression and fibrosis in liver tissues and low serum protein levels compared to controls. This is the first report of a consistent model of IRI-induced NASH capable of mimicking clinical findings.
- 1 August 2014
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 74 (4) , 711-720
Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model
Nonalcoholic steatohepatitis (NASH) has been associated with irinotecan (IRI)-based cancer chemotherapy regimens. The purpose of this study was to propose and test a consistent model of IRI-induced NASH, filling a gap in the medical literature. Swiss male mice were distributed in groups (n = 8) and injected with saline (5 mL/kg, i.p.; control) or IRI (25, 50, 75 or 100 mg/kg, i.p.) thrice a week for 7 weeks. Blood samples were collected to measure the serum concentrations of proteins, alanine and aspartate aminotransferases (ALT and AST). Each week animals were euthanized, and the livers were submitted to myeloperoxidase (MPO) assay, lipid dosage, immunohistochemistry for inducible nitric oxide synthase (iNOS), TNF-α and interleukin-1β (IL-1β), and histopathological analysis. Survival rates were also determined. Mice treated with IRI had a significantly (p < 0.05) lower survival rate than controls and time- and dose-dependent body weight loss. ALT and AST plasma levels increased in relation to controls only in mice receiving IRI 50 mg/kg (p < 0.05). The histopathological features characteristic of NASH was observed, including steatosis, lobular neutrophil infiltration and ballooning hepatocytic degeneration. Additional findings included increased MPO, lipid accumulation, portal neutrophil infiltration, IL-1β and iNOS expression and fibrosis in liver tissues and low serum protein levels compared to controls. This is the first report of a consistent model of IRI-induced NASH capable of mimicking clinical findings.
- 1 July 2014
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 70 (1) , 70-72
A handcrafted tissue microarray for a matrix arrangement of tissue samples
- 1 July 2014
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 70 (1) , 70-72
A handcrafted tissue microarray for a matrix arrangement of tissue samples
- 15 March 2012
- Published by Elsevier in Pathology - Research and Practice
- Vol. 208 (3) , 167-168
An adapted tissue microarray for the development of a matrix arrangement of tissue samples
- 15 March 2012
- Published by Elsevier in Pathology - Research and Practice
- Vol. 208 (3) , 167-168
An adapted tissue microarray for the development of a matrix arrangement of tissue samples
- Open Access
- 1 January 2012
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (8) , 778-84
Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases
To evaluate immunoexpression of cyclooxygenase-2 (COX-2) in primary gastric carcinomas and respective lymph node metastases. Immunohistochemistry to analyze COX-2 expression was performed on tissue microarray slices obtained from 36 specimens of gastrectomy and satellite lymph nodes from patients with gastric carcinoma. Immunostaining was seen in most cases, and COX-2 expression was higher in lymph node metastases than in corresponding primary gastric tumors of intestinal, diffuse and mixed carcinomas, with a statistically significant difference in the diffuse histotype (P = 0.0108). COX-2 immunoexpression occurs frequently in primary gastric carcinomas, but higher expression of this enzyme is observed in lymph node metastases of the diffuse histotype.
- 1 January 2012
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (8) , 778-84
Open AccessImmunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases
To evaluate immunoexpression of cyclooxygenase-2 (COX-2) in primary gastric carcinomas and respective lymph node metastases. Immunohistochemistry to analyze COX-2 expression was performed on tissue microarray slices obtained from 36 specimens of gastrectomy and satellite lymph nodes from patients with gastric carcinoma. Immunostaining was seen in most cases, and COX-2 expression was higher in lymph node metastases than in corresponding primary gastric tumors of intestinal, diffuse and mixed carcinomas, with a statistically significant difference in the diffuse histotype (P = 0.0108). COX-2 immunoexpression occurs frequently in primary gastric carcinomas, but higher expression of this enzyme is observed in lymph node metastases of the diffuse histotype.